Etiometry
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Etiometry, Inc. is an American medical technology company based in Boston, Massachusetts, founded in 20101. It develops the Etiometry Platform (also known as the T3 Platform), a regulated medical device software system for intensive care units (ICUs). According to product documentation, the platform aggregates real-time physiologic data and employs risk analytics to help clinicians identify early signs of deterioration in pediatric and adult critical care settings. It has received FDA 510(k) clearances, CE marking under EU Medical Device Regulation (MDR), and Health Canada licensing. Peer-reviewed publications have assessed the platform's clinical utility as a clinical decision support system, and published case studies have documented its use in academic intensive care units.
Etiometry, Inc. is an American medical technology company based in Boston, Massachusetts, founded in 2010. It develops the Etiometry Platform (also known as the T3 Platform), a regulated medical device software system for intensive care units (ICUs). According to product documentation, the platform aggregates real-time physiologic data and employs risk analytics to help clinicians identify early signs of deterioration in pediatric and adult critical care settings. It has received FDA 510(k) clearances, CE marking under EU Medical Device Regulation (MDR), and Health Canada licensing. Peer-reviewed publications have assessed the platform's clinical utility as a clinical decision support system, and published case studies have documented its use in academic intensive care units. ==References==
Text derived from https://en.wikipedia.org/w/index.php?oldid=1354152614 under CC BY-SA 4.0; modifications have been made.